The impact has been vast and further preclinical studies are still necessary to explore and understand the potential of the drugs that have already revolutionised the lives of millions of people with obesity and type 2 diabetes
Berberine, a bioactive alkaloid derived from various plants, including Berberis species, has garnered significant attention as a nutraceutical agent due to its potential benefits in metabolic health
Individuals using GLP-1 treatments, such as those in programs like Tyde Wellness, report an average body weight reduction of 15% after 68 weeks, with many achieving weight loss of over 20-25% within a year
Analysis of the Long-Term Impact of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Control of Obesity and Obesity-Related Comorbidities: A Meta-Analysis
Stay hydrated and manage side effects Common side effects of GLP-1 agonists include nausea, constipation and feeling overly full
Conclusions GLP-1 RAs appear to elevate bioavailable testosterone and improve glycemic control, while effects on free testosterone and SHBG remain inconclusive